Stonepine Capital Management LLC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 10:28 am Sale | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management LLC | 0 0.000% | -4,006,185 (Position Closed) | Filing |
| 2022-02-11 5:47 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management LLC | 4,006,185 5.900% | 506,185 (+14.46%) | Filing |
| 2021-04-29 4:48 pm Purchase | 2021-04-20 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management LLC | 3,500,000 5.300% | 3,500,000 (New Position) | Filing |